EndoChoice (GI) Misses Q1 EPS by 13c
Get Alerts GI Hot Sheet
Join SI Premium – FREE
EndoChoice (NYSE: GI) reported Q1 EPS of ($0.68), $0.13 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $18.34 million.
GUIDANCE:
EndoChoice sees FY2016 EPS of ($2.01)-($1.95), versus the consensus of ($1.99). EndoChoice sees FY2016 revenue of $86-93 million, versus the consensus of $88.1 million.
For earnings history and earnings-related data on EndoChoice (GI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- NaaS Technology Inc. (NAAS) Reports Q1 Loss of $0.29
- Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!